Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS In Brief

This article was originally published in The Gray Sheet

Executive Summary

New Acting CMO

You may also be interested in...



HHS Seeks Industry Input On National Quality Strategy

HHS expects device and drug manufacturers, as well as other industry stakeholders, to provide ongoing feedback to aid the agency's development of its official National Quality Strategy for health care, the agency said in a March 21 report to Congress.

HHS Seeks Industry Input On National Quality Strategy

HHS expects device and drug manufacturers, as well as other industry stakeholders, to provide ongoing feedback to aid the agency's development of its official National Quality Strategy for health care, the agency said in a March 21 report to Congress.

Patient-Safety Efforts To Be Scaled Up In HHS Initiative

HHS plans to unveil "the largest national effort on patient safety ever seen," CMS Administrator Donald Berwick said at a health policy meeting last week in Washington, D.C.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel